How to Structure a Peptide Clinic: Entity, CPOM, and the S-Corp Election

A peptide clinic is a medical practice. That single sentence drives most of the entity decisions a founder will make. Wellness branding, cash-pay billing, and a retail-style patient experience do not change the underlying legal character of the work. A licensed clinician is prescribing, compounding pharmacies are dispensing, and patients are receiving injectable therapy under supervision. The structure has to reflect that reality before the tax planning can do any useful work. This piece walks through the structural choices in the order they matter.

First Question - What State Are You In?

Before anyone files an LLC or talks about an S-corp election, the founder needs to know whether the clinic will operate in a Corporate Practice of Medicine state. CPOM doctrine restricts non-physician ownership of entities that practice medicine. The list of CPOM states includes California, Texas, New York, New Jersey, Illinois, Ohio, Pennsylvania, Oregon, and Washington, among others. Non-CPOM states permit broader ownership structures, including ownership by non-clinicians or by passive investors, though professional-entity, licensing, and fee-splitting rules still call for state-specific review.

The state determines the floor of what is possible. A non-physician founder in California cannot own the clinical entity outright, no matter how the operating agreement is drafted. A non-physician founder in a non-CPOM state can. Everything that follows - entity type, tax election, payroll setup, even the chart of accounts - is downstream of this single jurisdictional question.

In a CPOM State - The PC/PLLC + MSO Structure

The standard answer in a CPOM state is a two-entity structure. The clinical entity is a Professional Corporation or Professional Limited Liability Company, and it generally must satisfy the state's professional ownership rules - in most CPOM states that means ownership by a licensed physician, though some states authorize other specific licensees. This is the entity that holds the medical license, employs or contracts with clinicians, bills for clinical services, and carries malpractice exposure.

Sitting alongside it is a Management Services Organization. The MSO is typically an LLC or S-corp and can be owned by the operator or investor group without medical licensure restrictions, subject to state limits on fee splitting and control of clinical decisions. The MSO handles every non-clinical function the business needs to run: the lease, equipment financing, marketing, IT, scheduling software, non-clinical staffing administration, and back-office accounting.

The two entities are linked by a Management Services Agreement. The MSA defines what the MSO provides, how it is compensated, and the boundaries that keep the MSO from controlling clinical decision-making. Tax flow follows the contract: the clinical entity recognizes clinical revenue, pays the MSO a fair-market management fee for the services rendered, and distributes the remainder to the physician owner. The MSO recognizes the management fee as revenue and runs its own profit-and-loss against its own expense stack.

This is a structure that needs counsel to draft correctly. The MSA terms, the fee methodology, and the scope of services have to align with the relevant state's CPOM enforcement posture. Calyx works alongside the operator's healthcare attorney to align the tax filings to the legal structure - making sure the books, the returns, and the intercompany flows reflect what the legal documents actually say.

Oregon operators should read this section twice. Our home state enacted Senate Bill 951 in 2025, codifying and strengthening its corporate practice of medicine doctrine and placing significant new restrictions on MSO ownership and control of professional medical entities - including limits on dual ownership and on the contractual levers MSOs have traditionally used. New arrangements generally must comply beginning in 2026, and existing structures generally have until 2029. The conventional PC-plus-MSO playbook described above should not be implemented in Oregon without a review against SB 951 by healthcare counsel, and existing Oregon structures deserve the same review well before the compliance deadline.

In a Non-CPOM State - The Simpler Stack

In a non-CPOM state, the structural question gets a lot easier. A single PLLC or LLC owned by the operator or operators is often sufficient to run the clinic. There is no required split between a clinical entity and a management entity, no MSA to draft, and no intercompany fee to calculate.

The default path is to form the entity, elect tax treatment that fits the projected economics, and run one set of books. One entity, one bank account, one chart of accounts, one return at year-end. Most peptide clinics in non-CPOM states will sit here for years before there is any reason to add complexity. If the business eventually opens a second location, brings on a partner, or expands into a CPOM state, the structure can be revisited then.

The S-Corp Election - When and Why

The S-corp election is the single most important tax decision most clinic owners will make in the first few years of operation. An LLC taxed as a sole proprietorship or partnership generally pays self-employment tax on the full net profit allocated to an active owner. An LLC that elects S-corp treatment splits the owner's compensation into two pieces: a W-2 wage and a profit distribution. Self-employment tax - specifically the Social Security and Medicare components - is paid only on the W-2 wages, not on the distributions.

The catch is reasonable compensation. The IRS requires that S-corp owner-employees be paid a wage that reflects the fair market value of the services they actually perform. Underpaid S-corp owner wages are a documented IRS audit target, and the penalty for getting it wrong is reclassification of distributions as wages, plus back payroll taxes, plus interest and penalties.

The rough planning lever is straightforward. Once net profit exceeds the reasonable W-2 baseline by a meaningful margin, the self-employment tax savings on the distribution piece justify the additional payroll filings, the bookkeeping cost, and the corporate return. Below that threshold, the election adds cost without much benefit. Calyx runs the exact analysis per client - looking at projected revenue, the owner's clinical role, comparable wages in the local market, and the cash-flow profile of the business - before recommending the election or the timing of it.

Compensation for the Medical Director

Most peptide clinics need a medical director or supervising physician of record; in full-practice-authority states, a nurse practitioner may fill that role. How that person is paid depends on the relationship.

If the clinical director is a W-2 employee of the practice - typical for an owner-physician in a non-CPOM state, or for a director who runs day-to-day clinical operations - payroll is straightforward. Withholding, employer taxes, quarterly 941 filings, and the annual W-2 all run through the normal payroll system.

If the medical director is an independent contractor providing supervision under a written agreement - common where a physician provides contracted supervision to a clinic owned and operated by a nurse practitioner where state law permits that model, or where the director also runs a separate practice - 1099 treatment may be appropriate. The contract has to be real, the relationship has to look like an independent contractor relationship in substance, and the state board rules often dictate the answer regardless of what the parties would prefer. Some boards require a level of supervisory presence that effectively forecloses contractor treatment. Check the board rule before drafting the agreement.

Bookkeeping Disciplines for a Peptide Clinic

A peptide clinic's books should reflect the way the business actually operates, which is part medical practice and part retail. A few disciplines matter from day one:

• Separate clinical revenue from product revenue. A consultation, an injection administration, and an over-the-counter product sale have different sales tax treatment in many states. Mixing them in a single revenue account makes the year-end sales tax reconciliation painful and increases the audit risk if the state ever asks for backup.
• Track inventory of injectable product. Peptides held for in-clinic administration are inventory, not supplies. They sit on the balance sheet until used, and they flow through cost of goods sold when administered. This matters for gross margin reporting, for tax timing, and for any future financing conversation.
• Track HSA/FSA-eligible versus cash-pay transactions. Patients increasingly ask for documentation that supports HSA or FSA reimbursement. The cleanest way to handle this is to tag transactions at the point of sale so the client-facing reporting writes itself.
• Run a monthly close. A clinic that closes its books every month catches inventory shrinkage, payroll errors, and revenue recognition issues while they are still small. A clinic that closes once a year at tax time finds out about them after the fact, when they are expensive to fix.

The Tax Returns You Will File

Once the structure is in place and the books are clean, the filing calendar is predictable. A typical peptide clinic will file:

• Federal entity return: Form 1120-S for an S-corp election, or Form 1065 for a multi-member LLC taxed as a partnership. The CPOM clinic-plus-MSO structure files two entity returns - one for each.
• State corporate and franchise returns: per state, on the state's own schedule and forms.
• Payroll returns: Form 941 quarterly for federal income tax withholding and FICA, and Form 940 annually for federal unemployment.
• Sales tax returns: per state nexus rules, on the cadence the state requires - usually monthly or quarterly depending on volume.
• Owner return: Form 1040 with K-1 flow-through from the entity return, plus any estimated tax payments required during the year.

None of this is exotic. The work is in getting the structure and the books right so that the returns are the easy part.

Get the Entity Right First

The order of operations matters. Pick the state, then pick the structure the state permits, then pick the tax election that fits the projected economics, then build the books to support both. Founders who try to optimize the tax piece before settling the structural piece end up rebuilding the entity stack a year in, which is expensive and disruptive. Founders who get the structure right at the start file clean returns from day one and spend their attention on the clinic, not on cleanup.

Calyx CPA structures peptide clinics in both CPOM and non-CPOM states, working alongside healthcare counsel where the structure requires it and running the full tax and bookkeeping function for the practice once it is open.

This article is intended for informational purposes only and does not constitute legal, tax, or medical advice.